UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gold(I)-Catalyzed Enantioselective Synthesis of Pyrazolidines, Isoxazolidines, and Tetrahydrooxazines

Angewandte Chemie (International ed.), 2010-01, Vol.49 (3), p.598-601

2010

Volltextzugriff (PDF)

Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Clinical pharmacology and therapeutics, 2013-06, Vol.93 (6), p.502-514

2013

Volltextzugriff (PDF)

Model-based Drug Development

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.21-32

2007

Volltextzugriff (PDF)

Drug Development Perspective on Pharmacokinetic Studies of New Drugs in Patients With Renal Impairment

Clinical pharmacology and therapeutics, 2009-11, Vol.86 (5), p.557-561

2009

Volltextzugriff (PDF)

Nontraditional approaches to first-in-human studies to increase efficiency of drug development: will microdose studies make a significant impact?

Clinical pharmacology and therapeutics, 2007-01, Vol.81 (1), p.24-26

2007

Volltextzugriff (PDF)

The Use of a Clinical Utility Index to Compare Insomnia Compounds: A Quantitative Basis for Benefit-Risk Assessment

Clinical pharmacology and therapeutics, 2009-03, Vol.85 (3), p.277-282

2009

Volltextzugriff (PDF)

Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Clinical pharmacology and therapeutics, 2013-06, Vol.93 (6), p.502-514

2013

Volltextzugriff (PDF)

Clinical Pharmacology in the Era of Biotherapeutics

Clinical pharmacology and therapeutics, 2008-11, Vol.84 (5), p.533-536

2008

Volltextzugriff (PDF)

Differential actinodin1 regulation in zebrafish and mouse appendages

Developmental biology, 2016-09, Vol.417 (1), p.91-103

2016

Volltextzugriff (PDF)

Comparison of QTc Data Analysis Methods Recommended by the ICH E14 Guidance and Exposure-Response Analysis: Case Study of a Thorough QT Study of Asenapine

Clinical pharmacology and therapeutics, 2011-01, Vol.89 (1), p.75-80

2011

Volltextzugriff (PDF)

Comparative Efficacy and Effectiveness: An Opportunity for Clinical Pharmacology

Clinical pharmacology and therapeutics, 2011-12, Vol.90 (6), p.761-763

2011

Volltextzugriff (PDF)

Introduction of Quantitative Methods in Pharmacology and Clinical Pharmacology: A Historical Overview

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.3-6

2007

Volltextzugriff (PDF)

Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer

Cancer chemotherapy and pharmacology, 2000, Vol.46 (3), p.227-234

2000

Volltextzugriff (PDF)

A Single‐Blind, Crossover Comparison of the Pharmacokinetics and Cognitive Effects of a New Diazepam Rectal Gel with Intravenous Diazepam

Epilepsia (Copenhagen), 1998-05, Vol.39 (5), p.520-526

1998

Volltextzugriff (PDF)

Truncated area under the curve as a measure of relative extent of bioavailability : Evaluation using experimental data and Monte Carlo simulations

Pharmaceutical research, 1998-10, Vol.15 (10), p.1621-1629

1998

Volltextzugriff (PDF)

Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568

Clinical pharmacology and therapeutics, 1999-01, Vol.65 (1), p.40-49

1999

Volltextzugriff (PDF)

Technical note: Preparation and purification of atmospherically relevant α-hydroxynitrate esters of monoterpenes

Atmospheric chemistry and physics, 2020-04, Vol.20 (7), p.4241-4254

2020

Volltextzugriff (PDF)

How modeling and simulation have enhanced decision making in new drug development

Journal of pharmacokinetics and pharmacodynamics, 2005-04, Vol.32 (2), p.185-197

2005

Volltextzugriff (PDF)

Population pharmacokinetics of terfenadine

Pharmaceutical research, 1996-06, Vol.13 (6), p.832-838

1996

Volltextzugriff (PDF)

Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma

Annals of allergy, asthma, & immunology, 1999-04, Vol.82 (4), p.377-382

1999

Volltextzugriff (PDF)

Gold(I)‐Catalyzed Enantioselective Synthesis of Pyrazolidines, Isoxazolidines, and Tetrahydrooxazines

Angewandte Chemie, 2010-01, Vol.122 (3), p.608-611

2010

Volltextzugriff (PDF)

Comparison of different methods to evaluate population dose-response and relative potency : Importance of interoccasion variability

Journal of pharmacokinetics and biopharmaceutics, 1999-02, Vol.27 (1), p.67-83

1999

Volltextzugriff (PDF)

Gold(I)-Catalyzed Enantioselective Synthesis of Pyrazolidines, Isoxazolidines, and Tetrahydrooxazines

Angewandte Chemie, 2010-01, Vol.122 (3), p.608-611

2010

Volltextzugriff (PDF)

Calcium Channel Blockers as Inhibitors of Drug Metabolism

Chest, 1989-08, Vol.96 (2), p.393-399

1989

Volltextzugriff (PDF)

Effects of age on the protein binding and disposition of propranolol stereoisomers

Clinical pharmacology and therapeutics, 1990-04, Vol.47 (4), p.447-455

1990

Volltextzugriff (PDF)

1 – 25 von 367

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(325)
Mit Volltextzugriff
(290)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(250)
Life Sciences & Biomedicine
(225)
Humans
(156)
Biological And Medical Sciences
(121)
Medical Sciences
(109)
Male
(103)
Female
(91)
Adult
(83)
Middle Aged
(58)
Animals
(53)
Pharmacology & Pharmacy
(52)
Pharmacology. Drug Treatments
(52)
Aged
(42)
Infectious Diseases
(34)
Physical Sciences
(30)
Hiv
(24)
Adolescent
(23)
Chemistry
(22)
Fundamental And Applied Biological Sciences. Psychology
(21)
Human Immunodeficiency Virus
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Gold(I)-Catalyzed Enantioselective Synthesis of Pyrazolidines, Isoxazolidines, and Tetrahydrooxazines

Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Model-based Drug Development

Drug Development Perspective on Pharmacokinetic Studies of New Drugs in Patients With Renal Impairment

Nontraditional approaches to first-in-human studies to increase efficiency of drug development: will microdose studies make a significant impact?

The Use of a Clinical Utility Index to Compare Insomnia Compounds: A Quantitative Basis for Benefit-Risk Assessment

Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Clinical Pharmacology in the Era of Biotherapeutics

Differential actinodin1 regulation in zebrafish and mouse appendages

Comparison of QTc Data Analysis Methods Recommended by the ICH E14 Guidance and Exposure-Response Analysis: Case Study of a Thorough QT Study of Asenapine

Comparative Efficacy and Effectiveness: An Opportunity for Clinical Pharmacology

Introduction of Quantitative Methods in Pharmacology and Clinical Pharmacology: A Historical Overview

Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer

A Single‐Blind, Crossover Comparison of the Pharmacokinetics and Cognitive Effects of a New Diazepam Rectal Gel with Intravenous Diazepam

Truncated area under the curve as a measure of relative extent of bioavailability : Evaluation using experimental data and Monte Carlo simulations

Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568

Technical note: Preparation and purification of atmospherically relevant α-hydroxynitrate esters of monoterpenes

How modeling and simulation have enhanced decision making in new drug development

Population pharmacokinetics of terfenadine

Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma

Gold(I)‐Catalyzed Enantioselective Synthesis of Pyrazolidines, Isoxazolidines, and Tetrahydrooxazines

Comparison of different methods to evaluate population dose-response and relative potency : Importance of interoccasion variability

Gold(I)-Catalyzed Enantioselective Synthesis of Pyrazolidines, Isoxazolidines, and Tetrahydrooxazines

Calcium Channel Blockers as Inhibitors of Drug Metabolism

Effects of age on the protein binding and disposition of propranolol stereoisomers

Suchergebnisse filtern